The innovative drug concept continued to be strong in early trading. Baihua Pharmaceutical had 3 consecutive sales, while Rongchang Biotech, Smart Pharmaceuticals, Wanbang Pharmaceuticals, BeiGene Shenzhou, Xinjiangjiang, and Sanyuan Gene had higher gains.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.